News & Events about Coherus Biosciences Inc.
Additional Growth Driver Projected to Significantly Increase Mid-to-Long Term Revenue PotentialREDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus or Coherus BioSciences, Nasdaq: CHRS) announced today that it has executed a binding term sheet with Klinge ...
Market News Video
1month ago
In trading on Wednesday, shares of Coherus BioSciences Inc (CHRS) crossed above their 200 day moving average of 9.03, changing hands as high as 10.19 per share. Coherus BioSciences Inc shares are currently trading up about 19% on the day...
- FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA - - Junshi Biosciences and Coherus are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC in the...
- FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA - - Coherus and Junshi Biosciences are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC in the...
Thinking about buying stock in ReShape Lifesciences, Exicure, Blue Apron, Coherus Biosciences, or Icecure Medical? Thinking about buying stock in ReShape Lifesciences, Exicure, Blue Apron, Coherus Biosciences, or Icecure Medical? PR Newswire NEW YORK, Dec. 23, 2022 NEW YORK, Dec. 23, 2022...